Tuesday, July 12, 2016

Agency Cites Five Drug Compounders on Sterility, Adulteration Concerns

The FDA has cited five U.S.-based drug compounders in as many weeks, with most of the complaints focusing on sterility issues, although questions of adulteration and issuing unapproved drugs also surfaced. Read More

No comments: